Simple randomization did not protect against bias in smaller trials.
暂无分享,去创建一个
Paul Landais | André Lamy | Yannick Le Manach | Tri-Long Nguyen | Jean-Pierre Daurès | G. Collins | J. Daurès | P. Devereaux | P. Landais | Tri-Long Nguyen | Y. Le Manach | A. Lamy | Gary S. Collins | Philip J. Devereaux
[1] L. Messer,et al. Reporting Discrepancies Between the ClinicalTrials . gov , 2014 .
[2] R. Peto,et al. Clinical trial methodology , 1978, Nature.
[3] G. Guyatt,et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.
[4] S Greenland,et al. Interpretation and choice of effect measures in epidemiologic analyses. , 1987, American journal of epidemiology.
[5] Jeroen J. Bax,et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. , 2009, The New England journal of medicine.
[6] S. Assmann,et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.
[7] Philippe Ravaud,et al. Quality of reporting of noninferiority and equivalence randomized trials. , 2006, JAMA.
[8] S. Pocock,et al. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.
[9] P. Sandercock,et al. The International Stroke Trial database , 2011, Trials.
[10] Gary King,et al. The essential role of pair matching in cluster-randomized experiments, with application to the Mexican Universal Health Insurance Evaluation , 2009, 0910.3752.
[11] S. Pocock,et al. Design of Major Randomized Trials: Part 3 of a 4-Part Series on Statistics for Clinical Trials. , 2015, Journal of the American College of Cardiology.
[12] Caroline Leigh Watkins. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997 .
[13] Gary King,et al. Misunderstandings between experimentalists and observationalists about causal inference , 2008 .
[14] Douglas G Altman,et al. Treatment allocation in controlled trials: why randomise? , 1999, BMJ.
[15] R Peto,et al. Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.
[16] D. G. Altman,et al. Randomisation and baseline comparisons in clinical trials , 1990, The Lancet.
[17] E. Akl,et al. Randomisation to protect against selection bias in healthcare trials. , 2011, The Cochrane database of systematic reviews.
[18] S. Pocock,et al. Estimation issues in clinical trials and overviews. , 1990, Statistics in medicine.
[19] A. Rigby. Cross‐over Trials in Clinical Research , 2003 .
[20] S. Pocock,et al. Randomized trials, statistics, and clinical inference. , 2010, Journal of the American College of Cardiology.
[21] Douglas G Altman,et al. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. , 2010, JAMA.
[22] D. Harrison,et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. , 2014, JAMA.
[23] Denis Xavier,et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.
[24] H. Krumholz,et al. Reporting of results in ClinicalTrials.gov and high-impact journals. , 2014, JAMA.
[25] S. Senn. Testing for baseline balance in clinical trials. , 1994, Statistics in medicine.
[26] Peter Sandercock,et al. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.
[27] Gordon H Guyatt,et al. GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .
[28] Robert M Califf,et al. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. , 2012, JAMA.
[29] S. Pocock,et al. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems , 2002, Statistics in medicine.
[30] B. Biccard,et al. Vascular events in noncardiac Surgery patients cohortevaluation study (Vision) Nt-pro-BNP sub study. A large multicentre international cohort study evaluating NT-pro-BNP in major vascular events in patients undergonig noncardiac surgery , 2011 .
[31] Gary King,et al. Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference , 2007, Political Analysis.
[32] J. Bland,et al. The tyranny of power: is there a better way to calculate sample size? , 2009, BMJ : British Medical Journal.
[33] Donald B. Rubin,et al. Comment: The Design and Analysis of Gold Standard Randomized Experiments , 2008 .
[34] E F Cook,et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.
[35] Richard A. Nielsen,et al. Why Propensity Scores Should Not Be Used for Matching , 2019, Political Analysis.
[36] M. Gail,et al. Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates , 1984 .
[37] J. Lachin. Properties of simple randomization in clinical trials. , 1988, Controlled clinical trials.
[38] David Moher,et al. Comparison of registered and published primary outcomes in randomized controlled trials. , 2009, JAMA.
[39] S. Yusuf,et al. Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes , 2014, Anesthesiology.
[40] T. Treasure,et al. Minimisation: the platinum standard for trials? , 1998, BMJ.
[41] Jeffrey H Silber,et al. Optimal multivariate matching before randomization. , 2004, Biostatistics.
[42] S J Senn,et al. Covariate imbalance and random allocation in clinical trials. , 1989, Statistics in medicine.
[43] F. Song,et al. Dissemination and publication of research findings: an updated review of related biases. , 2010, Health technology assessment.
[44] Sally Hopewell,et al. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed , 2010, BMJ : British Medical Journal.
[45] Douglas G. Altman,et al. RANDOMISATION : ESSENTIAL FOR REDUCING BIAS , 1991 .